Clinical Trial Update: Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose radiotherapy with durvalumab and chemotherapy for extensive-stage small-cell lung cancer (ES-SCLC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: You Lu | Conditions: Lung Cancer, Extensive-stage Small-cell Lung Cancer | Phase 2 | Status: UNKNOWN